Drug
Sel 302
Sel 302: highest development phase Phase 1/2, developed by Selecta Biosciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Selecta Biosciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| SEL-302 NCT05778877 | Phase 1/2 | Methylmalonic Acidemia (MMA) |
Latest
No recent events.
Follow Sel 302 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.